allulose sugar glp-1 Secretion of but not GIP is potently stimulated by luminal d-Allulose (d-Psicose) in rats gram package GLP-1 release and vagal afferent

Clinical Evidence for Dual-Peptide Weight Loss Therapy Published data on GLP-1 monotherapy shows average weight loss of 1522% over 68 weeks in phase 3 trials, with sustained improvements in waist circumference and cardiometabolic markers

Stacking multiple peptides Taking multiple peptides requires understanding interactions and timing

Until now, obesity treatment has largely resembled elective healthcare available primarily to individuals who could afford expensive medications

Medication & Medical History Review Some prescriptions interfere with how vitamins function or how the body metabolizes them

Rosa, D

Companies can leverage this interest in natural alternatives to GLP-1 medications to guide R&D and create differentiated products positioned for consumers seeking natural metabolic-health support